StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences total product sales ($M) ($M)

Form 10-Q / 10-K Disaggregated Revenue Note & Form 8-K Product Sales Summary

QuarterlyAnnual
Latest, FY2025
28,915
Period ended Dec 31, 2025
Change on a year earlier
+1.1%
28,610 in FY2024
History
10 years
Since FY2016
Sources
7
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal product sales ($M) ($M)Year on yearSource
FY2025Dec 31, 202528,915+1.1%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 202428,610+6.2%Form 10-K (filed 2026-02-24) ↗
FY2023Dec 31, 202326,934-0.2%Form 10-K (filed 2026-02-24) ↗
FY2022Dec 31, 202226,982-0.1%Form 10-K (filed 2025-02-28) ↗
FY2021Dec 31, 202127,008+10.9%Form 10-K (filed 2024-02-23) ↗
FY2020Dec 31, 202024,355+10.1%Form 10-K (filed 2023-02-22) ↗
FY2019Dec 31, 201922,119+2.0%Form 10-K (filed 2022-02-23) ↗
FY2018Dec 31, 201821,677-15.5%Form 10-K (filed 2021-02-25) ↗
FY2017Dec 31, 201725,662-14.3%Form 10-K (filed 2019-02-26) ↗
FY2016Dec 31, 201629,953–Form 10-K (filed 2019-02-26) ↗

Breakdown

What makes up total product sales ($m)

Cite this data

StockData. (2026). Gilead Sciences Total product sales ($M) ($M), annual FY2016–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/rev_product_sales

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.